Last Price
339.05
Today's Change
+1.77 (0.52%)
Day's Change
335.32 - 340.38
Trading Volume
181,258
Market Cap
10 Billion
Shares Outstanding
31 Million
Avg Volume
377,620
Avg Price (50 Days)
339.31
Avg Price (200 Days)
374.88
PE Ratio
29.72
EPS
11.41
Earnings Announcement
10-Feb-2025
Previous Close
337.28
Open
337.68
Day's Range
335.3201 - 340.385
Year Range
277.72 - 459.77
Trading Volume
181,258
1 Day Change
0.52%
5 Day Change
-3.40%
1 Month Change
0.38%
3 Month Change
-6.33%
6 Month Change
-16.08%
Ytd Change
10.95%
1 Year Change
8.43%
3 Year Change
51.79%
5 Year Change
301.77%
10 Year Change
1120.04%
Max Change
1120.04%
No result.
Sector: Healthcare - Healthcare
Industry: Diagnostics & Research
Description:
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.